Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18421194rdf:typepubmed:Citationlld:pubmed
pubmed-article:18421194lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18421194lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18421194lifeskim:mentionsumls-concept:C0018213lld:lifeskim
pubmed-article:18421194lifeskim:mentionsumls-concept:C0003811lld:lifeskim
pubmed-article:18421194lifeskim:mentionsumls-concept:C0002598lld:lifeskim
pubmed-article:18421194lifeskim:mentionsumls-concept:C0011906lld:lifeskim
pubmed-article:18421194lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:18421194lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:18421194lifeskim:mentionsumls-concept:C1548787lld:lifeskim
pubmed-article:18421194lifeskim:mentionsumls-concept:C1556066lld:lifeskim
pubmed-article:18421194lifeskim:mentionsumls-concept:C1619636lld:lifeskim
pubmed-article:18421194lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:18421194pubmed:issue8lld:pubmed
pubmed-article:18421194pubmed:dateCreated2008-4-18lld:pubmed
pubmed-article:18421194pubmed:abstractTextWe report the treatment of four thyrotoxic patients. Two were cases of type I amiodarone-induced thyrotoxicosis (AIT) treated with methimazole. The third Graves' disease patient, who became hypothyroid 25 years after subtotal thyroidectomy, developed type II AIT. Furthermore, one case with heart failure and ventricular tachycardia, who developed an adverse reaction to antithyroid agents and was prescribed amiodarone, underwent total thyroidectomy. The clinical course was uneventful, and the patient is doing well. Since amiodarone contains a large amount of iodine, it is frequently difficult to make a differential diagnosis. Surgical treatment of Graves' disease patients is recommended when immediate control of hyperthyroidism and heart failure is required.lld:pubmed
pubmed-article:18421194pubmed:languageenglld:pubmed
pubmed-article:18421194pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18421194pubmed:citationSubsetIMlld:pubmed
pubmed-article:18421194pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18421194pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18421194pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18421194pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18421194pubmed:statusMEDLINElld:pubmed
pubmed-article:18421194pubmed:issn1349-7235lld:pubmed
pubmed-article:18421194pubmed:authorpubmed-author:KasanukiHiros...lld:pubmed
pubmed-article:18421194pubmed:authorpubmed-author:SekiToshiroTlld:pubmed
pubmed-article:18421194pubmed:authorpubmed-author:ShigaTsuyoshi...lld:pubmed
pubmed-article:18421194pubmed:authorpubmed-author:YamadaEmikoElld:pubmed
pubmed-article:18421194pubmed:authorpubmed-author:ObaraTakaoTlld:pubmed
pubmed-article:18421194pubmed:authorpubmed-author:TakanoKazueKlld:pubmed
pubmed-article:18421194pubmed:authorpubmed-author:SatoKanjiKlld:pubmed
pubmed-article:18421194pubmed:authorpubmed-author:YamazakiKazuk...lld:pubmed
pubmed-article:18421194pubmed:authorpubmed-author:OmiYokoYlld:pubmed
pubmed-article:18421194pubmed:authorpubmed-author:KodamaHitomiHlld:pubmed
pubmed-article:18421194pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18421194pubmed:volume47lld:pubmed
pubmed-article:18421194pubmed:ownerNLMlld:pubmed
pubmed-article:18421194pubmed:authorsCompleteYlld:pubmed
pubmed-article:18421194pubmed:pagination757-62lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:meshHeadingpubmed-meshheading:18421194...lld:pubmed
pubmed-article:18421194pubmed:year2008lld:pubmed
pubmed-article:18421194pubmed:articleTitleDifferential diagnosis and appropriate treatment of four thyrotoxic patients with Graves' disease required to take amiodarone due to life-threatening arrhythmia.lld:pubmed
pubmed-article:18421194pubmed:affiliationDepartment of Medicine, Institute of Clinical Endocrinology, Tokyo Women's Medical University, Tokyo. satokan@attglobal.netlld:pubmed
pubmed-article:18421194pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18421194pubmed:publicationTypeCase Reportslld:pubmed